Can I get more lip filler with mild telangiectasia and mild fibrosis? (Photos)

Thank you for sharing your story and photos — your attention to detail and care in understanding your biopsy results are very thoughtful.

Based on your description, the findings of mild telangiectasia (small visible blood vessels) and mild fibrosis (slight scar-like tissue formation) are consistent with localized tissue changes that can occur after repeated filler injections. The small focus of “amorphous material” likely represents residual filler from a prior treatment.

If you’re considering more filler, it’s very important to proceed cautiously. The area with fibrosis has altered tissue structure and blood flow, which means filler placed too close to that region may not integrate smoothly or could increase the risk of unevenness, delayed healing, or even vascular irritation.

If you and your injector decide to move forward, the safest approach would be to avoid injecting directly into or near the affected right upper lip area. Focusing instead on the opposite side of the upper lip or the lower lip, as you mentioned, can minimize risk.

Between Volbella and Ultra, Volbella is thinner and more subtle, often preferred for refined touch-ups or in areas with prior filler activity or sensitivity. However, your injector should assess the firmness and depth of your existing filler before making that decision.

As for infection risk, if the skin is fully healed from the biopsy and there’s no ongoing inflammation, the risk remains low — but it’s still slightly higher in areas that have been previously manipulated or scarred. A clean technique and experienced injector are key.

In summary:

Wait until the biopsy site and surrounding tissue are fully healed.

Avoid the previously affected right upper lip area.

Consider a conservative product like Volbella for any additional filler.

Ensure your injector is fully aware of your biopsy results before treatment.

Your lips can still look beautiful and balanced with a thoughtful, cautious approach.